Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
54 Leser
Artikel bewerten:
(0)

Governor Quinn Announces Illinois Healthcare Research Coalition Awarded $7 Million to Battle Chronic Illnesses

CHICAGO, Dec. 17, 2013 /PRNewswire/ -- Governor Quinn today announced that a coalition of 20 health and hospital organizations from Illinois has been awarded an 18-month, $7million federal award to establish a clinical data research network (CDRN). Awarded by the Patient-Centered Outcomes Research Institute (PCORI), the coalition will be part of a larger national network that will model how healthcare institutions in complex urban settings improve health outcomes and drive down costs for both rare and common conditions such as sickle cell disease, asthma, anemia, recurrent clostridium difficile, obesity and diabetes.

"Through this unique collaboration of our incredibly talented researchers, Illinois is helping lead the fight against chronic illnesses that affect millions of Americans," Governor Quinn said. "This coalition will be able to ultimately touch upon millions of lives and make a positive impact on disease prevention and improving health outcomes."

The coalition, the Chicago Area Patient Centered Outcomes Research Network (CAPriCORN), will pool data from more than 1 million patients so researchers locally and nationwide can learn how providers can overcome barriers of competition, care fragmentation and limited resources. This will aid in the development, testing and implementation of effective strategies to improve care for diverse populations and reduce health disparities. This unprecedented collaboration will be led by The Chicago Community Trust (CCT) with administrative support of the Illinois Medical District Commission (IMDC).

Better decision-making, greater engagement

PCORI, established in 2010, is authorized by Congress to conduct research to provide information about the best available evidence to help patients and their healthcare providers make more informed decisions.

The mission of CAPriCORN is to provide a data and informatics infrastructure to support collaboration among Chicago-area scientists in conducting patient-centered outcomes research, with an ultimate goal of improving patient outcomes.

The award will be used for numerous activities across the CAPriCORN initiative, including: compiling clinical data; designing systems to conduct Comparative Effectiveness Research trials and observational studies in the Chicago area and nationally; establishing procedures for clinical data standardization and sharing across participating healthcare delivery institutions that can be used for performance measurement and quality improvement; engaging patients, clinicians and health system leadership in governance and use of CAPriCORN data resources; and recruiting and surveying clinical research study participants.

Collaborating for an important cause

Participating healthcare delivery institutions include:

  • Alliance of Chicago's Federally Qualified Health Centers
  • Cook County Health and Hospital Systems
  • Loyola University Health System
  • NorthShore University HealthSystem
  • Northwestern Medicine
  • Rush University Medical Center
  • University of Illinois Hospital & Health Sciences System
  • University of Chicago Medicine
  • Veterans Administration Hospitals (Hines, Jesse Brown)

Other CAPriCORN partners include:

  • The Chicago Community Trust
  • Illinois Medical District Commission
  • University HealthSystem Consortium (UHC)
  • University of Illinois at Chicago
  • Chicago Health IT Regional Extension Center (CHITREC)
  • Medical Research Analytics and Informatics Alliance
  • Center for Medical Technology Policy
  • Clinical Directors Network
  • RAND
  • Tufts University CTSI
  • Vanderbilt University

CAPriCORN is supported by the Illinois Department of Healthcare and Family Services, the Illinois Office of Health Information Technology, the Cook County Government and the Chicago Department of Public Health.

Advocacy groups supporting CAPriCORN include: Respiratory Health Association, Chicago Asthma Consortium, Sickle Cell Disease Association of Illinois, Peggy Lillis Mills Foundation, Have a Heart for Sickle Cell Anemia Foundation and Next Step/STRIVE. Blue Cross and Blue Shield of Illinois is also a supporter of CAPriCORN.

In preparation for this award, CAPriCORN has already pooled clinical data from electronic health records to identify patients and potential study participants for the anticipated research. In addition, five of the CAPriCORN institutions already collaborate with the Chicago-based UHC, an alliance of 119 nonprofit academic medical centers, more than 300 affiliated hospitals, and nearly 100 faculty practice plans. UHC will expand its role to serve as a data aggregator for all CAPriCORN sites.

About PCORI

The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work. More information is available at www.pcori.org. PCORI has awarded a total of $464.4 million since it began funding CER in 2012. For more information about PCORI funding, visit http://pcori.org/funding-opportunities.

SOURCE Office of the Governor Pat Quinn

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.